Literature DB >> 2662234

Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.

A Georgotas1, R E McCue, T B Cooper, N Nagachandran, A Friedhoff.   

Abstract

Seventy-six elderly depressed patients who had responded to either nortriptyline or phenelzine after a trial of up to 3 months were examined. The mean week of response was nearly 6 weeks. Patients who were more severely depressed took longer to respond. Patients with endogenous depression responded sooner on nortriptyline than did patients with nonendogenous depression. For patients on nortriptyline, lower plasma levels in the early weeks of treatment may delay response while differences in platelet monoamine oxidase inhibition in the early weeks of treatment do not appear to affect week of response for patients on phenelzine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2662234     DOI: 10.1016/0165-1781(89)90192-3

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

1.  Abnormal Expression of MicroRNAs Induced by Chronic Unpredictable Mild Stress in Rat Hippocampal Tissues.

Authors:  Min Zhou; Maohua Wang; Xiaobin Wang; Kezhi Liu; YunQiang Wan; Mao Li; Li Liu; Chunxiang Zhang
Journal:  Mol Neurobiol       Date:  2017-01-12       Impact factor: 5.590

2.  Management of resistant depression.

Authors:  L Warneke
Journal:  Can Fam Physician       Date:  1996-10       Impact factor: 3.275

Review 3.  Selective serotonin reuptake inhibitors in older patients. A tolerability perspective.

Authors:  U Skerritt; R Evans; S A Montgomery
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

Review 4.  Antidepressant versus placebo for depressed elderly.

Authors:  K Wilson; P Mottram; A Sivanranthan; A Nightingale
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 5.  Managing resistant depression. When patients do not respond to therapy.

Authors:  L Warneke
Journal:  Can Fam Physician       Date:  1993-04       Impact factor: 3.275

Review 6.  Time course of response to antidepressants in late-life major depression: therapeutic implications.

Authors:  Ellen M Whyte; Mary Amanda Dew; Ariel Gildengers; Eric J Lenze; Ashok Bharucha; Benoit H Mulsant; Charles F Reynolds
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Targeted alterations in dietary n-3 and n-6 fatty acids improve life functioning and reduce psychological distress among patients with chronic headache: a secondary analysis of a randomized trial.

Authors:  Christopher E Ramsden; Keturah R Faurot; Daisy Zamora; Olafur S Palsson; Beth A MacIntosh; Susan Gaylord; Ameer Y Taha; Stanley I Rapoport; Joseph R Hibbeln; John M Davis; J Douglas Mann
Journal:  Pain       Date:  2015-04       Impact factor: 7.926

8.  Which drug for which patient? Is there a fluoxetine responding versus a bupropion responding personality profile?

Authors:  D Stewart Bell; W Mark Shipman; Mario A Cleves; Jill Siegelman
Journal:  Clin Pract Epidemiol Ment Health       Date:  2013-07-12

Review 9.  Monoamine oxidase inhibitors. A perspective on their use in the elderly.

Authors:  H P Volz; C H Gleiter
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 4.271

10.  MicroRNA as therapeutic targets for treatment of depression.

Authors:  Katelin F Hansen; Karl Obrietan
Journal:  Neuropsychiatr Dis Treat       Date:  2013-07-29       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.